Aim: Patients with pharyngitis often describe various sensory, affective and evaluative pain qualities. Using an 11-word/phrase index, the Qualities of Sore Throat Index (QuaSTI), we characterized throat symptoms and evaluated changes in a randomized controlled trial (NCT01986361).
Materials & Methods: Patients received a single flurbiprofen 8.75 mg (n = 101) or placebo (n = 21) lozenge and rated throat soreness at baseline and regular intervals over 3 h, and the QuaSTI at baseline, 1, 2 and 3 h post-treatment.
Results: The QuaSTI distinguished active drug from placebo and detected clinically important (≥2-point) changes over 3 h. Mean change from baseline over 3 h was significantly greater for flurbiprofen (154%) than placebo (p < 0.05).
Conclusion: The QuaSTI is a sensitive instrument for measuring therapeutic effects in patients with pharyngitis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2217/pmt-2017-0041 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!